CordovaCann (LVRLF) Other Non-Current Liabilities (2009 - 2020)
CordovaCann (LVRLF) recorded quarterly Other Non-Current Liabilities of $93453.6 in Q2 2020, down 91.53% quarter-over-quarter from $1.1 million in Q3 2010.
CordovaCann (LVRLF) Other Non-Current Liabilities (2009 - 2020) Analysis & Trends
CordovaCann's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $93453.6 for Q2 2020.
- In Q2 2020, Other Non-Current Liabilities changed N/A year-over-year to $93453.6; the TTM figure through Jun 2020 stood at $93453.6 (changed N/A YoY), while the FY2020 annual figure was $96624.7, changed N/A from the prior year.
- Other Non-Current Liabilities was $93453.6 for Q2 2020 at CordovaCann, down from $1.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $93453.6 in Q2 2020 to a low of $93453.6 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CordovaCann | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 93,453.61 |
| Sep 30, 2010 | 1.10 Mn |
| Mar 31, 2010 | 1.10 Mn |
| Dec 31, 2009 | 1.09 Mn |
| Sep 30, 2009 | 1.04 Mn |
| Jun 30, 2009 | 981,233.05 |
| Mar 31, 2009 | 922,152.39 |